Bart Vannieuwenhuyse


Senior Director Health Information Sciences, Janssen Pharmaceuticals.

In 1985, Bart joined Janssen Pharmaceutica as a clinical trial monitor. In the course of his career with Janssen, Bart has held a variety of marketing and sales positions, both at local operating company level (e.g. the Netherlands) and at international level. While […]

Johan Liwing


Director Market Access RWE Partnerships, Global Commercial Strategy Organization, Janssen

Johan is currently Director Market Access RWE Partnerships at Janssen and part of its global RWE leadership team. In his current role Johan is coordinating efforts of developing close collaborations between Janssen and other parties in RWE research. Furthermore, Johan […]

Duane Schulthess


CEO, Vital Transformation

Duane Schulthess is the CEO of Vital Transformation, a consultancy focused on quantifying and defining innovation and change in the health-care sector. He regularly works with regulators, multi-national corporations, governments, and stakeholder groups, clarifying the impact of health policy changes and technological innovations.

He […]

Ferran Sanz


Professor of Biomedical Informatics and Biostatistics at the Universitat Pompeu Fabra (UPF, Barcelona), Director of the Research Programme on Biomedical Informatics (GRIB) of the UPF and the Hospital del Mar Institute of Medical Research (IMIM, Barcelona).

Author of more than 130 articles in ISI-indexed journals. Coordinator of nine EU-funded initiatives, […]

Andrew Roddam


Vice President and Head of Real World Evidence, GSK

Andrew is currently Vice President and Head of Real World Evidence at GSK and is a renowned expert in epidemiological research with specific interest in the utilisation of routine data for research purposes. He acts as an advisor to a number […]

Dipak Kalra


President, EuroRec; EHR4CR

Dipak Kalra plays a leading international role in research and development of Electronic Health Record architectures and systems, including the requirements and models needed to ensure the robust long-term preservation of clinical meaning and protection of privacy. He leads the development of CEN (European Committee for Standardization) […]

Nigel Hughes


Director Health Information Sciences, Quantitative Sciences, Janssen Pharm R&D

A former UK NHS healthcare & voluntary sector professional working in the pharmaceutical and diagnostics industry with a 360° experience in the blood borne virus market based on a professional heritage in the viral hepatitis, liver disease & HIV […]

Ron MC Herings, PhD FISPE


Scientific Director, PHARMO

Dr. Herings is the Scientific Director and a founder of the PHARMO Institute. He is trained as pharmacist, holds a PhD in pharmacoepidemiology from Utrecht University and is specialized in the design, governance, implementation and analyses of large research database networks detailing the use of pharmaceuticals and […]

Sarah Garner


Associate Director, Research and Development, National Institutes of Clinical Excellence

Dr Sarah Garner PhD, BPharm is a pharmacist specialising in Health Technology Assessment (HTA). Sarah is the Associate Director for R&D at the UK’s National Institute for Health and Clinical Excellence (NICE) and is responsible for the planning and delivery […]

Go to Top